Microbix Engages with Diagnostics Industry Experts

About this update from Microbix Biosystems Inc.

Microbix Engages with Diagnostics Industry ExpertsReleasing Episodes of Season Two of "Diagnostics: Beyond the Lab" Podcast MISSISSAUGA, ON / ACCESS Newswire / April 20, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it is releasing three episodes of the second season of its podcast titled "Diagnostics: Beyond the Lab." This Microbix podcast series engages with third-party experts to discuss opportunities and challenges facing the diagnostics industry - to inform policy-makers, medical or scientific professionals, and patients.The Diagnostics: Beyond the Lab podcast series is hosted by Microbix's CEO, Cameron Groome, and its episodes are of approximately 60 minutes in duration. Three episodes of season two of the podcast are being made available, with the following expert guests:Mr. James Yantzi, President of Seegene Canada, a provider of lab-based molecular multiplex testing and automation systems. James discusses the challenges and opportunities related to the adoption of new diagnostic technologies in Canada and reviews where novel tests can best improve domestic health outcomes while reducing system costs and bottlenecks.Dr. Simon Patton, CEO of UK-based EMQN, a provider of external quality assessment (EQA) programs to help ensure the accuracy and reliability of point-of-care genetic tests. Simon discusses his experiences in building EQA for this new field of testing, how to ensure positive outcomes at both lab and point-of-care testing sites, and to secure funding across jurisdictions.Dr. Tanya Applegate and Ms. Stacey Foster-Rampant of the Kirby Institute of NSW Australia, an organization providing diagnostic testing services to remote communities and aboriginal peoples. Tanya and Stacey discuss how the Kirby Institute has built trust and engagement with cultures that have deep-rooted distrust of government and top-down health programs, leading to meaningful improvements in both health access and outcomes for isolated populations.Cameron Groome, CEO & President of Microbix, commented "Whether in Canada, across the Atlantic, or on the other side of the world, Microbix is engaged with thought leaders who are making important diagnostics innovations available to healthcare providers and their patients. Microbix is proud to count these guests, and others, as de...

View stock analysis, news, and events for Microbix Biosystems Inc.